Licensing
Partnerships
We have established licensing in and out with various companies.
▼Achievements of the past 10 years
The names of partner companies and products are as they were at the time of the press release
| Year | Partner | Product | Therapeutic Areas | Partnering Form |
|---|---|---|---|---|
| 2024 | Eli Lilly Japan K.K (Japan) | Pirtobrutinib | Hematology | Marketing right |
| 2024 | Vicore Pharma Holding AB (Sweden) | C21 | Intractable/rare diseases | Development and Marketing right |
| 2023 | Capricor Therapeutics, Inc. (USA) | CAP-1002 | Neuromuscular disease | Marketing right (Japan) |
| 2022 | Capricor Therapeutics, Inc. (USA) | CAP-1002 | Neuromuscular disease | Marketing right (USA) |
| 2021 | The Menarini Group (Italy) | Tagraxofusp | Hematology | Development and Marketing right |
| 2020 | Janssen Pharmaceutical K.K (Japan) | ZITIGA® (Abiraterone) |
Urology | Co-promotion |
| 2019 | Zogenix, Inc. (USA) | ZX008 (Fenfluramine) |
Intractable/rare diseases | Development and Marketing right |
| 2019 | Janssen Pharmaceutical K.K (Japan) | Apalutamide | Urology | Co-promotion |
| 2017 | Jazz Pharmaceuticals (Ireland) | Defitelio® （Defibrotide) |
Hematology | Development and Marketing right |
| 2017 | Jazz Pharmaceuticals (Ireland) | Vyxeos® (Liposomal formulation of cytarabine and daunorubicin) |
Hematology | Development and Marketing right |
| 2017 | Delta-Fly Pharma, Inc. (Japan) | DFP-10917 (Radgocitabine) |
Hematology | Development and Marketing right |
| 2016 | Pharmacosmos A/S (Denmark) | Monofer® (Ferric derisomaltose) |
Gynecology, other | Development and Marketing right |
| 2015 | Merck serono (Japan) | GONAL-f® (Follitropin alfa) |
Gynecology | Co-promotion |